Genezen

Genezen is a contract development and manufacturing organization (CDMO) based in Indianapolis, Indiana, specializing in viral vector manufacturing for gene and cell therapies. The company operates cGMP-compliant facilities in Fishers, Indiana, and Lexington, Massachusetts, focusing on advancing therapies from discovery to clinical and commercial production. Founded with a commitment to technical excellence, Genezen offers end-to-end services, including process development, cGMP manufacturing, and analytical testing for various viral vectors such as lentiviral and retroviral. The company has experienced significant growth, highlighted by a 424% revenue increase from 2017 to 2019 and recognition as Indiana’s fastest-growing company in 2020. Genezen expanded its operations in 2022 with a new facility in Fishers, enhancing its capacity for viral vector production. The company collaborates with biotech and pharmaceutical firms to provide flexible and scalable manufacturing solutions, aiming to accelerate the delivery of innovative therapies.